Dividend Assets Capital, LLC Merck & Co., Inc. Transaction History

Dividend Assets Capital, LLC

$519 Million
Q3 2024

A detailed history of Dividend Assets Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dividend Assets Capital, LLC holds 7,852 shares of MRK stock, worth $779,311. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,852

Previous 7,793 0.76%

Holding current value

$779,311

Previous $964,000 7.57%

% of portfolio

0.17%

Previous 0.2%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $6,557 - $7,609	59 Added 0.76%	7,852 $891,000
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $123 - $132	1 Added 0.01%	7,793 $964,000
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $72,586 - $84,579	641 Added 8.96%	7,792 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $12,021 - $13,082	-120 Reduced 1.65%	7,151 $780,000
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $35,517 - $39,443	-345 Reduced 4.53%	7,271 $749,000
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $27,152 - $29,595	-250 Reduced 3.18%	7,616 $879,000
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $18,362 - $23,543	-210 Reduced 2.6%	7,866 $873,000
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $84,107 - $94,485	-995 Reduced 10.97%	8,076 $696,000
Q2 2022 Jul 15, 2022	BUY	$83.49 - $94.64 $8,766 - $9,937	105 Added 1.17%	9,071 $827,000
Q1 2022 Apr 12, 2022	BUY	$73.51 - $82.4 $67,335 - $75,478	916 Added 11.38%	8,966 $736,000
Q4 2021 Feb 23, 2022	SELL	$72.28 - $90.54 $15,178 - $19,013	-210 Reduced 2.54%	8,050 $617,000
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $10,752 - $11,824	-150 Reduced 1.78%	8,260 $620,000
Q4 2020 Jan 22, 2021	BUY	$71.77 - $79.65 $14,354 - $15,930	200 Added 2.44%	8,410 $688,000
Q3 2020 Oct 19, 2020	BUY	$73.18 - $82.95 $18,295 - $20,737	250 Added 3.14%	8,210 $681,000
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $45,420 - $51,683	-645 Reduced 7.5%	7,960 $616,000
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $32,630 - $45,227	-515 Reduced 5.65%	8,605 $662,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $29,092 - $32,827	375 Added 4.29%	9,120 $829,000
Q3 2019 Oct 25, 2019	BUY	$76.08 - $82.93 $48,310 - $52,660	635 Added 7.83%	8,745 $736,000
Q2 2019 Jul 12, 2019	SELL	$69.84 - $81.59 $11,872 - $13,870	-170 Reduced 2.05%	8,110 $680,000
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $2,783 - $3,174	-40 Reduced 0.48%	8,280 $689,000
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $268,788 - $311,925	-4,120 Reduced 33.12%	8,320 $636,000
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $188,934 - $222,176	-3,275 Reduced 20.84%	12,440 $882,000
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $8,895 - $10,451	175 Added 1.13%	15,715 $954,000
Q1 2018 May 02, 2018	BUY	$50.96 - $59.23 $114,405 - $132,971	2,245 Added 16.89%	15,540 $846,000
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $86,721 - $103,555	-1,680 Reduced 11.22%	13,295 $748,000
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $878,583 - $945,371	14,975	14,975 $959,000

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dividend Assets Capital, LLC with notifications on news.

Account

Dividend Assets Capital, LLC Merck & Co., Inc. Transaction History